The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo - Scali,C.; Giovannini,M.G.; Prosperi,C.; Bellucci,A.; Pepeu,G.; Casamenti,F. (Neuroscience, 2003)